Trial Profile
Phase 0 clinical study of very low single-dose Azilsartan Trimethylethanolamine to healthy Chinese male volunteers
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Azilsartan trimethylethanolamine (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 20 Jun 2016 New trial record